Outcomes of patients with secondary central nervous system lymphoma treated with chimeric antigen receptor T-cell therapy: A CIBMTR analysis.
Epperla N, Hashmi H, Ahn KW, Allbee-Johnson M, Chen AI, Wirk B, Kanakry JA, Lekakis L, Kharfan-Dabaja MA, Scordo M, Riedell PA, Jain T, Shadman M, Sauter C, Hamadani M, Herrera AF, Ahmed S.
Epperla N, et al. Among authors: ahmed s.
Br J Haematol. 2024 May 26. doi: 10.1111/bjh.19569. Online ahead of print.
Br J Haematol. 2024.
PMID: 38797526
No abstract available.